Publications by authors named "Emiko Mura"

Background/aim: The Kaplan-Meier curves for patients treated with immune checkpoint inhibitors (ICIs) display a small group of potentially-cured patients with long-term survival, creating a 'kangaroo-tail' shape of the survival curve. However, the mechanistic basis of this phenomenon and what occurs in patients whose cancer is resistant to ICIs remain unclear. The present study aimed to answer these questions.

View Article and Find Full Text PDF

Introduction: Immune checkpoint inhibitors (ICIs) have emerged as a promising treatment option for esophageal cancer (EC). Although ICIs enable long-term survival in some patients, the efficacy of ICIs varies widely among patients. Therefore, predictive biomarkers are necessary for identifying patients who are most likely to benefit from ICIs to improve the efficacy of the treatment.

View Article and Find Full Text PDF

Background: Heart failure (HF) patients with complex care needs often experience exacerbations during the transitional phase as care providers and settings change. Regional collaboration aims to ensure continuity of care; however, its impact on vulnerable patients certified as needing support or care under the Japanese long-term care insurance (LTCI) system remains unclear.

Methods And Results: We implemented a regional collaborative program for HF patients involving 3 pillars of transitional care with general practitioners and nursing care facilities: (1) standardized health monitoring using a patient diary and identification of exacerbation warning signs; (2) standardized information sharing among care providers; and (3) standardized HF management manuals.

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors (ICIs), like nivolumab, are being studied for treating esophageal cancer, but long-term survival rates are low and some patients face serious side effects.
  • A study of 86 esophageal cancer patients on nivolumab found that factors like performance status, neutrophil-to-lymphocyte ratio (NLR), and sex significantly affected overall and progression-free survival rates.
  • Results indicated that patients with a low NLR (less than 3.3) and good performance status before treatment had better survival outcomes, suggesting NLR could be a useful biomarker for predicting treatment response.
View Article and Find Full Text PDF

Evidence on transitional care for heart failure (HF) in Japan is limited. We implemented a transitional HF management program in rural Japan in 2019. This involved collaboration with general practitioners or nursing care facilities and included symptom monitoring by medical/nursing staff using a handbook; standardized discharge care planning and information sharing on self-care and advance care planning using a collaborative sheet; and sharing expertise on HF management via manuals.

View Article and Find Full Text PDF

Background: With the aging of heart failure (HF) patients, collaboration between medical and nursing care facilities is essential for HF care. The aims of this study were: (1) to identify the factors that affect willingness of nursing care staffs to cooperate with HF care; (2) to test whether the internet video education is useful in improving their willingness to collaborate.

Methods: A web-based questionnaire was e-mailed to 417 registered medical corporations that operated nursing care facilities in the prefecture where the authors work.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the potential for non-classical monocytes (NCMs) to improve the effectiveness of immune checkpoint inhibitors (ICIs) in colon cancer, which typically have a low response rate.
  • Using a mouse model with colon cancer, researchers treated the mice with a combination of ICIs and NCMs and found that this combination was more effective than ICIs alone.
  • The results indicate that while NCMs enhance the response to ICIs, they do not work effectively on their own; further research will explore how this works and its potential clinical applications.
View Article and Find Full Text PDF

Introduction: Programmed cell death ligand 1 (PD-L1) expression in tumor tissues is measured as a predictor of the therapeutic efficacy of immune checkpoint inhibitors (ICIs) in many cancer types. PD-L1 expression is evaluated by immunohistochemical staining using 3,3´-diaminobenzidine (DAB) chronogenesis (IHC-DAB); however, quantitative and reproducibility issues remain. We focused on a highly sensitive quantitative immunohistochemical method using phosphor-integrated dots (PIDs), which are fluorescent nanoparticles, and evaluated PD-L1 expression between the PID method and conventional DAB method.

View Article and Find Full Text PDF

The increased numbers of older and frail patients with heart failure (HF) means there is an urgent need to establish regional collaborative systems for medical and nursing care. However, expectations related to collaborative HF care among medical and care staff remain unclear. We conducted a questionnaire survey with staff in hospitals, clinics, and nursing care facilities (NCFs) who had experienced collaboration through the common HF collaborative pathway in the western region of Tottori Prefecture, Japan, from July 2019 to July 2020.

View Article and Find Full Text PDF